# 바이오스페이스 일일 뉴스 리포트 - 2025년 09월 04일


## 주요 헤드라인

1. **Pfizer CEO Responds to Trump’s COVID Transparency Call Touting Vaccine Success (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/pfizer-ceo-responds-to-trumps-covid-transparency-call-touting-vaccine-success>

2. **Pfizer CEO Responds to Trump’s COVID Transparency Call Touting Vaccine Success (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/pfizer-ceo-responds-to-trumps-covid-transparency-call-touting-vaccine-success>

3. **RFK Jr. Blames US COVID Deaths on Chronic Disease, Announcing CDC Reorganization (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/rfk-jr-blames-us-covid-deaths-on-chronic-disease-announcing-cdc-reorganization>

4. **RFK Jr. Blames US COVID Deaths on Chronic Disease, Announcing CDC Reorganization (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/rfk-jr-blames-us-covid-deaths-on-chronic-disease-announcing-cdc-reorganization>

5. **Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novartis-spending-spree-continues-with-5-2b-argo-sirna-pact>

6. **Ionis’ Tryngolza Hits ‘Best-Case Scenario’ in Late-Stage Triglyceride Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/ionis-tryngolza-hits-best-case-scenario-in-late-stage-triglyceride-study>

7. **Cytokinetics Soars on Aficamten’s ‘Best-in-Class’ Performance in Phase III Cardio Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/cytokinetics-soars-on-aficamtens-best-in-class-performance-in-phase-iii-cardio-study>


---
*2025년 09월 04일 바이오스페이스 뉴스 피드에서 생성된 리포트*